 Thanks, Delencia. In this morning's Medical Alert, the FDA has now approved a new Alzheimer's drug from Eli Lilly for people with early stages of the disease. Eli Lilly says Donanumab has now been shown in clinical trials to modestly slow the decline in memory and thinking abilities in people with Alzheimer's.